Skip to main content

Access to patient-level data from GlaxoSmithKline clinical trials.

Publication ,  Journal Article
Nisen, P; Rockhold, F
Published in: N Engl J Med
August 1, 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

August 1, 2013

Volume

369

Issue

5

Start / End Page

475 / 478

Location

United States

Related Subject Headings

  • Internet
  • Information Dissemination
  • Humans
  • General & Internal Medicine
  • Drug Industry
  • Drug Evaluation
  • Confidentiality
  • Clinical Trials as Topic
  • Access to Information
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nisen, P., & Rockhold, F. (2013). Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med, 369(5), 475–478. https://doi.org/10.1056/NEJMsr1302541
Nisen, Perry, and Frank Rockhold. “Access to patient-level data from GlaxoSmithKline clinical trials.N Engl J Med 369, no. 5 (August 1, 2013): 475–78. https://doi.org/10.1056/NEJMsr1302541.
Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013 Aug 1;369(5):475–8.
Nisen, Perry, and Frank Rockhold. “Access to patient-level data from GlaxoSmithKline clinical trials.N Engl J Med, vol. 369, no. 5, Aug. 2013, pp. 475–78. Pubmed, doi:10.1056/NEJMsr1302541.
Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013 Aug 1;369(5):475–478.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

August 1, 2013

Volume

369

Issue

5

Start / End Page

475 / 478

Location

United States

Related Subject Headings

  • Internet
  • Information Dissemination
  • Humans
  • General & Internal Medicine
  • Drug Industry
  • Drug Evaluation
  • Confidentiality
  • Clinical Trials as Topic
  • Access to Information
  • 42 Health sciences